PAQR3 plays a suppressive role in the tumorigenesis of colorectal cancers

Carcinogenesis

Volumn 33, Issue 11, 2012, Pages 2228-2235

  Wang, Xiao ^a   Li, Xuebing ^a   Fan, Fengjuan ^a   Jiao, Shi ^a   Wang, Lingdi ^a   Zhu, Lu ^a   Pan, Yi ^a   Wu, Guohao ^b   Ling, Zhi Qiang ^c   Fang, Jing ^a   Chen, Yan ^a  

^a Chinese Academy of Sciences   (China)

^b FUDAN UNIVERSITY   (China)

^c ZHEJIANG CANCER HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; EPIDERMAL GROWTH FACTOR; MEMBRANE PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PROGESTIN AND ADIPOQ RECEPTOR FAMILY MEMBER 3; UNCLASSIFIED DRUG;

ADULT; AGED; ANCHORAGE INDEPENDENT GROWTH; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APC GENE; ARTICLE; CANCER CELL; CANCER GRADING; CARCINOGENESIS; CELL NUCLEUS; CELL PROLIFERATION; COLON POLYPOSIS; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; GENE; GENE DELETION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SURVIVAL TIME; TUMOR VOLUME;

ADENOMATOUS POLYPOSIS COLI PROTEIN; ADULT; AGED; ANIMALS; BETA CATENIN; BLOTTING, WESTERN; CELL PROLIFERATION; COLONY-FORMING UNITS ASSAY; COLORECTAL NEOPLASMS; EPIDERMAL GROWTH FACTOR; FEMALE; HUMANS; MALE; MAP KINASE SIGNALING SYSTEM; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; PHOSPHORYLATION; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, PROGESTERONE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SURVIVAL RATE;

EID: 84868610225     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgs245     Document Type: Article

References (32)

1. Jemal, A. et al. (2011) Global cancer statistics. CA Cancer J. Clin., 61, 69-90.
2. Center, M.M. et al. (2009) Worldwide variations in colorectal cancer. CA Cancer J. Clin., 59, 366-378.
3. Groden, J. et al. (1991) Identification and characterization of the familial adenomatous polyposis coli gene. Cell, 66, 589-600.
4. Kinzler, K.W. et al. (1991) Identification of a gene located at chromosome 5q21 that is mutated in colorectal cancers. Science, 251, 1366-1370.
5. Nishisho, I. et al. (1991) Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. Science, 253, 665-669.
6. Bisgaard, M.L. et al. (1994) Familial adenomatous polyposis (FAP): frequency, penetrance, and mutation rate. Hum. Mutat., 3, 121-125.
7. Galiatsatos, P. et al. (2006) Familial adenomatous polyposis. Am. J. Gastroenterol., 101, 385-398.
8. Powell, S.M. et al. (1992) APC mutations occur early during colorectal tumorigenesis. Nature, 359, 235-237.
9. Moser, A.R. et al. (1990) A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. Science, 247, 322-324.
10. Su, L.K. et al. (1992) Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene. Science, 256, 668-670.
11. Moser, A.R. et al. (1995) Homozygosity for the Min allele of APC results in disruption of mouse development prior to gastrulation. Dev. Dyn., 203, 422-433.
12. Feng, L. et al. (2007) Spatial regulation of Raf kinase signaling by RKTG. Proc. Natl. Acad. Sci. U. S. A., 104, 14348-14353.
13. Luo, X. et al. (2008) Characterization of the topology and functional domains of RKTG. Biochem. J., 414, 399-406.
14. Fan, F. et al. (2008) RKTG sequesters B-Raf to the Golgi apparatus and inhibits the proliferation and tumorigenicity of human malignant melanoma cells. Carcinogenesis, 29, 1157-1163.
15. Xie, X. et al. (2008) Suppressive function of RKTG on chemical carcinogen-induced skin carcinogenesis in mouse. Carcinogenesis, 29, 1632-1638.
16. Zhang, Y. et al. (2010) RKTG inhibits angiogenesis by suppressing MAPK-mediated autocrine VEGF signaling and is downregulated in clear-cell renal cell carcinoma. Oncogene, 29, 5404-5415.
17. Jiang, Y. et al. (2011) Functional cooperation of RKTG with p53 in tumorigenesis and epithelial-mesenchymal transition. Cancer Res., 71, 2959-2968.
18. Mosmann, T. (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods, 65, 55-63.
19. Munker, R. et al. (1986) Vitamin D compounds. Effect on clonal proliferation and differentiation of human myeloid cells. J. Clin. Invest., 78, 424-430.
20. Phelps, R.A. et al. (2009) A two-step model for colon adenoma initiation and progression caused by APC loss. Cell, 137, 623-634.
21. Clevers, H. (2006) Wnt/beta-catenin signaling in development and disease. Cell, 127, 469-480.
22. Reya, T. et al. (2005) Wnt signalling in stem cells and cancer. Nature, 434, 843-850.
23. Barker, N. et al. (2000) Catenins, Wnt signaling and cancer. Bioessays, 22, 961-965.
24. Polakis, P. (2000) Wnt signaling and cancer. Genes Dev., 14, 1837-1851.
25. Morin, P.J. (1999) Beta-catenin signaling and cancer. Bioessays, 21, 1021-1030.
26. Polakis, P. (1999) The oncogenic activation of beta-catenin. Curr. Opin. Genet. Dev., 9, 15-21.
27. He, T.C. et al. (1998) Identification of c-MYC as a target of the APC pathway. Science, 281, 1509-1512.
28. Tetsu, O. et al. (1999) Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature, 398, 422-4226.
29. Malumbres, M. et al. (2003) RAS oncogenes: the first 30 years. Nat. Rev. Cancer, 3, 459-465.
30. Lee, S.H. et al. (2010) ERK activation drives intestinal tumorigenesis in APC(min/+) mice. Nat. Med., 16, 665-670.
31. Pollard, P. et al. (2009) The Apc 1322T mouse develops severe polyposis associated with submaximal nuclear beta-catenin expression. Gastroenterology, 136, 2204-2213 e1-13.
32. Blaker, H. et al. (2003) Somatic mutations in familial adenomatous polyps. Nuclear translocation of beta-catenin requires more than biallelic APC inactivation. Am. J. Clin. Pathol., 120, 418-423.